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Abstract: Numerous studies have analyzed the viability of the biodegradation and removal of
different compounds of emerging concern in biological systems for wastewater treatment. However,
the effect on the heterotrophic biomass of organic matter removal is sometimes missed. The aim
of the present research was to study the effect of the addition of a mix of three pharmaceuticals
(carbamazepine, ciprofloxacin, and ibuprofen) on the behavior of the biomass in two different
membrane-based biological systems treating urban wastewater. The present research studied a
membrane bioreactor (MBR) pilot plant operating at a similar mixed liquor suspended solids (MLSS)
concentration (about 5.5 g/L). This system works as an MBR and is combined with a moving bed
biofilm reactor (MBBR-MBR) to treat real urban wastewater at 6 and 10 h of hydraulic retention time
(HRT) under three different shocks of pharmaceuticals with increasing concentrations. In all cases,
the organic matter removal was, in average terms, higher than about 92% of biochemical oxygen
demand on the fifth day (BOD5), 79% of chemical oxygen demand (COD), and 85% of total organic
carbon (TOC). Nevertheless, the removal is higher in the MBBR-MBR technology under the same
HRT and the MLSS is similar. Moreover, the removal increased during the shock of pharmaceutical
compounds, especially in the MBR technology. From a kinetic perspective, MBBR-MBR is more
suitable for low HRT (6 h) and MBR is more effective for high HRT (10 h). This could be due to the fact
that biofilm systems are less sensitive to hostile environments than the MBR systems. The removal of
N-NH4+ decreased considerably when the pharmaceutical compounds mix was introduced into the
system until no removal was detected in cycle 1, even when biofilm was present.
Keywords: heterotrophic kinetics; membrane bioreactor; nitrogen; pharmaceutical shock
1. Introduction
Increasing attention has recently been paid to the presence of micropollutants in the aquatic
environment and wastewater treatment plants [1]. Recent studies have identified the presence of
contaminants of emerging concern (CECs) in effluents and in receiving waters, where CECs can
potentially affect aquatic organisms [2]. The presence of CECs, such as pharmaceuticals, personal
care products, or pesticides in the body of water, produces a major challenge to human health and
ecosystems [3]. CECs are not completely removed during wastewater treatments, and as a result,
they are discharged into the receiving streams and can end up in soils when the sewage sludge
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generated is employed as a fertilizer [4]. CECs are discharged into the environment throughout
effluents from wastewater treatment plants (WWTPs) that are not specifically designed for their
removal, and their impact is of particular relevance to wastewater disposal and re-use in agricultural
settings due to CEC uptake and the accumulation in food crops and their consequent diffusion into the
food-chain [5].
Numerous studies have analyzed the viability of the biodegradation and removal of different
CECs in biological systems for wastewater treatment, such as activated sludge (AS) or membrane
bioreactors (MBR). However, the effect on the heterotrophic biomass of organic matter removal is
sometimes missed. Pharmaceuticals in municipal WWTPs represent an important focus for reducing
micro-pollutant emissions because these compounds are used throughout the year and are designed to
produce specific biological effects on organisms or living tissue; therefore, they are also likely to cause
unwanted effects in the environment [1]. In biological WWTPs, the removal of organic matter relies on
the activity of a mixed community of heterotrophic microorganisms [6].
In the last decades, the MBR process has become an alternative to AS processes for the removal of
CECs and conventional pollutants (organic matter and nutrients) during wastewater treatment [7].
MBR technology has advantages such as absolute control of solid retention times and smaller volume
requirements [8], which improve, with an exceptional quality, its effluent so that it is capable of meeting
the most stringent water quality requirements [9].
The AS technology is based on the growth of biomass as floc; nevertheless, biomass can also attach
and grow on small carrier elements as biofilm in other technologies such as moving bed biofilm reactors
(MBBR) [10]. MBBR is a compact technology based on a mixed tank in which carriers, which move
freely around the bioreactor, are immersed and gradually colonize on the protected surface, growing
as biofilm [11].
The aim of the present research was to study the effect of the addition, at increasing concentrations,
of a mix of three pharmaceuticals (carbamazepine, ciprofloxacin, and ibuprofen) on the behavior of
the biomass in a conventional MBR and a hybrid MBBR-MBR when treating urban wastewater at
6 h and 10 h of hydraulic retention time (HRT). The concentrations of carbamazepine, ciprofloxacin,
and ibuprofen were 100, 10, and 100 µg/L, 1000, 100, and 1000 µg/L, and 5000, 500, and 5000 µg/L in
the doping cycles 1, 2, and 3, respectively. The lowest mixing ratio between the different chemicals
was based on the average values found in previous studies [12]; once the initial values were chosen,
increasing concentrations were used to check the bioreactor by keeping the initial ratio constant.
Moreover, this work was also designed to analyze the capacity of the bioreactor to adapt when different
concentrations of pharmaceutical mixes were introduced into the biological process.
2. Materials and Methods
2.1. Experimental Set-Up
The pilot plant used in this study was located in the WWTP Oeste of Granada (Spain) and was
continuously fed with real urban wastewater (Figure 1). It had a total treatment volume of 350 L
divided into two compartments, with a 272 L cylindrical tank in which the biological degradation
of organic matter and oxidation of ammonium were carried out by fine bubble aeration. Urban
wastewater was subsequently led by gravity to a second 78 L rectangular tank where the treated water
was separated from the mixed liquor by means of 4 submerged hollow fiber ultrafiltration membranes
with 0.04 µm nominal pore size and a 0.97 m2 unit surface area (ZW-10, ZENON®). To keep the
system well mixed and to maintain the working mixed liquor suspended solids (MLSS) concentration
(in mg/L), a pump recirculated the MLSS from the rectangular tank to the cylindrical tank.
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Figure 1. Schematic diagram of the pilot plant used in the research.
2.2. Operation Conditions
To achieve the objectives of the research, four experimental cycles were conducted at different
operating conditions (Table 1).
Table 1. Operation variables during the research.
Cycle MLSS (mg/L) HRT (h) Temperature (◦C) Filling Ratio (%) SRT (Days)
1 5643 ± 578 6 21.5 ± 3.1 - 11.2
2 5333 ± 304 10 12.6 ± 1.8 - 21.7
3 5773 ± 492 6 28.1 ± 2.7 35 6.0
4 5285 ± 280 10 17.6 ± 3.1 35 23.9
During cycles 1 and 2, the pilot plant was working as a submerged MBR for a period of 3 months
per cycle, during which samples were taken daily from influent, effluent, bioreactor, and excess sludge.
In cycle 1, the MBR was operated for 6 h of HRT, while in cycle 2, the MBR was working for 10 h
of HRT.
To operate the pilot plant as a hybrid MBBR-MBR treatment, in cycles 3 and 4, the cylindrical
bioreactor was filled with AnoxKaldnes™ K1 carriers with a 35% filling ratio, corresponding to a
175 m2/m3 net surface area in the bioreactor. In cycles 3 and 4, the hybrid MBBR-MBR system was
tested at similar concentrations of MLSS and identical values of HRT with respect to the MBR system
in cycles 1 and 2, respectively.
The temperature in each cycle was imposed by environmental conditions due to the outdoor
location of this plant, and the operation conditions determined the given sludge retention times (SRTs).
Once the performance of the pilot plant was assessed at the different conditions, the addition of
carbamazepine, ciprofloxacin, and ibuprofen into the influent made it possible to determine how the
presence of these pharmaceuticals affected organic matter and ammonium removal. For this purpose,
three different mixtures at increasing concentrations were added to the influent: The concentrations
of carbamazepine, ciprofloxacin, and ibuprofen were 100, 10, and 100 µg/L, 1000, 100, and 1000 µg/L,
and 5000, 500, and 5000 µg/L in dopings 1, 2, and 3, respectively. In light of this, the time necessary
to ensure that the selected concentration of pharmaceutical was available for the microorganisms,
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as a result of the dilution effect in the bioreactor, is an important variable to consider for the
assay. Consequently, a non-steady compound balance allowed for the prediction of the evolution
of the pharmaceutical in the bioreactor. From this balance, the time required to ensure the working
concentration of pharmaceutical was assessed according to Calero–Díaz et al. [12]. To simulate punctual
exposures to these pharmaceuticals, once the concentration of pharmaceutical was achieved, the pilot
plant was run for 3 days under each doping.
2.3. Physical and Chemical Determinations
Mixed liquor suspended solids (MLSS), chemical oxygen demand (COD), and biochemical oxygen
demand on the fifth day (BOD5) measurements were carried out according to procedures established in
the Standard Methods [13]. Total organic carbon (TOC) was determined by the difference between total
carbon and inorganic carbon in a Formacs HT TOC/TN analyzer by oxidative combustion at 950 ◦C.
Ammonium was measured by ionic chromatography with a Metrosep C4 column (Metrohm) using a
solution of dipicolinic acid as the eluent and distilled water as the regenerate. Conductivity and pH
were determined using a conductivity meter (Crison CM 35® Hach Lange Spain, S.L.U., L´Hospitalet
de Llobregat, Barcelona, Spain) and a pH meter (Crison pH 25®, Hach Lange Spain, S.L.U., L´Hospitalet
de Llobregat, Barcelona, Spain), respectively; the calibration of pH was carried out by using three
buffers, i.e., 4.01, 7.00, and 9.21, at 25 ◦C, while the calibration of conductivity was conducted by using
three buffers, i.e., 147 µS/cm, 1413 µS/cm, and 12.88 mS/cm, at 25 ◦C. The environmental temperature
was taken continuously in the pilot plant with a thermometer (LANGE LDOTM/sc100, Hach Lange
Spain, S.L.U., L´Hospitalet de Llobregat, Barcelona, Spain).
2.4. Kinetic Study
The influence of carbamazepine, ciprofloxacin, and ibuprofen on the heterotrophic biomass was
assessed during the steady state of the four operation cycles of the MBR and MBBR-MBR systems.
For this, biomass samples were taken from the previous biological systems and analyzed by respirometry
in a BM-Advance respirometer [14]. In light of this, the following kinetic parameters were determined
through exogenous and endogenous respirometric tests. On the one hand, the exogenous respiration
experiment allowed for the assessment of the maximum specific growth rate for heterotrophic biomass
(µm,H), half-saturation coefficient for organic matter (KM), and yield coefficient for heterotrophic
biomass (YH). On the other hand, the endogenous respiration experiment made it possible to
determine the decay coefficient for heterotrophic biomass (bH) [15]. Apart from the kinetic parameters
for heterotrophic bacteria, the substrate degradation rate for organic matter removal (rsu,H) was
evaluated for the control cycle (in the absence of pharmaceuticals) and three doping cycles under these
pharmaceuticals, according to Leyva–Díaz et al. [16], as shown in Equation (1):
rsu, H =
µm,H × S×XH
YH × (KM + S)
(1)
where S is the substrate concentration (mgO2 L−1) and XH is the concentration of heterotrophic biomass.
XH was estimated by applying the heterotrophic fraction (fH) to the mixed liquor volatile suspended
solids (MLVSS) concentration [17], as indicated in Equation (2):
XH = fH ×MLVSS (2)
2.5. Statistical Analysis
The results obtained from the analyses were treated using statistical software SPSS 20 for Windows.
A least significant differences (LSD) test was used to measure the differences between the results
obtained for each cycle. An analysis of variance (ANOVA) was used to assess the homogeneity of the
variance, with a confidence interval of 95%.
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3. Results and Discussion
3.1. Influent Characterization
The pilot plant was fed with real urban wastewater from the WWTP Oeste of Granada where the
pilot plant was located. The average values of the physical–chemical characteristics of the influent
during the four cycles represented in the present investigation are shown in Table 2.
Table 2. Average values of pH, conductivity, total suspended solids (TSS), and organic matter
concentration (Total organic carbon (TOC), chemical oxygen demand (COD), and BOD5) of the influent
during the experiments.
Cycle pH Conductivity(µS/cm) TSS (mg/L) TOC (mg/L) COD (mg/L)
BOD5
(mg/L)
1 8.04 ± 0.49 1394 ± 392 156 ± 49 208 ± 54 618 ± 123 344 ± 92
2 7.69 ± 0.29 1032 ± 164 144 ± 37 170 ± 36 495 ± 132 295 ± 87
3 7.53 ± 0.19 1267 ± 118 124 ± 26 210 ± 32 603 ± 99 367 ± 53
4 7.76 ± 0.40 1551 ± 751 139 ± 31 191 ± 36 597 ± 89 376 ± 75
The pH of the influent was relatively stable during the experimental period, it changed between
7.53 (cycle 3) and 8.54 (cycle 1), and presented the typical variation of real urban wastewater. Such values
are similar to those observed by other authors studying urban wastewater [18,19]. The conductivity
ranged between 1032 µS/cm (cycle 2) and 1550 µS/cm (cycle 4); in a unitary drainage network, the lowest
conductivity of the wastewater is related to a period of rain or particularly rainy days [20] throughout
the cycle, with minimum values of 580 µS/cm in cycle 4 and 700 µS/cm in cycle 2.
The average total suspended solids (TSS) of the influent changed from 124 to 156 mg/L throughout
four cycles. The organic matter was measured as TOC, COD, and BOD5 (Table 2) because it is water
with the presence of organic pollutants and it is necessary to know what the removal of organic matter
is in the effluent by relating the three ways of measuring it. The TOC provides the amount of carbon in
the sample and the BOD5/COD ratio shows the biodegradability of the organic carbon in the sample.
Considering the average data of the organic matter, some fluctuations were observed in the four cycles
studied because it is real urban wastewater.
The ANOVA test of the influent data did not show statistically significant differences, which
suggests that the variations in the results are due to the different operating variables of each cycle
(HRT, environmental temperature, and operating system).
3.2. Biological System Performance
The introduction of the pharmaceutical mix in the influent effected the biomass of the bioreactor
(Table 3).
Table 3. Average Mixed liquor suspended solids (MLSS) (mg/L) in steady state and the three dopings
for the four cycles studied.
Cycle Steady State Doping 1 Doping 2 Doping 3
1 5643 ± 578 5473 ± 501 5284 ± 369 4147 ± 963
2 5333 ± 304 4807 ± 326 4707 ± 792 -
3 5773 ± 492 5281 ± 540 5302 ± 104 4616 ± 139
4 5285 ± 280 4482 ± 587 4483 ± 398 3460 ± 541
In cycle 1, with the MBR system, the MLSS in the bioreactor was 5643 ± 578 mg/L, and with doping
at the highest concentration of pharmaceutical mix, almost 1500 mg/L of biomass was lost. The MLSS
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decrease with pharmaceuticals could be due to the shock in the system caused by the complexity of
these compounds the effected the different microorganisms [21]. In cycle 3, which is the analogue of
cycle 1, but with an MBBR-MBR system, observed a loss of 492 and 471 mg/L of biomass, respectively,
during the first two dopings, while for doping 3, a large decrease of the MLSS concentration was
observed in the hybrid MBBR-MBR system, although it was less pronounced compared to MBR.
This could be explained by the average temperature of 28.1 ◦C favoring a reduction of the shock of the
pharmaceutical mix on the biomass. This is due to the higher temperature having greater microbial
activity, which means that the biomass is adapted faster to the medium [22]. In cycle 2, with an
8.9 ◦C lower temperature than in cycle 1, the loss of biomass was high, and the cycle with the highest
concentration of doping could not be completed; this is because the low temperatures caused a shock
in the reactor, causing, in turn, the anomalous growth of bacteria. This leads to sludge bulking at
temperatures below 12–15 ◦C [23]. Gur–Reznik et al. [24] found, in their study with an MBR system,
that when the temperature is low, the metabolic rate undergoes changes affecting the degradation
of organic matter. Finally, cycle 4 lost more than 1800 mg/L during the three dopings, and was the
cycle that lost the largest amount of biomass. Something similar to cycle 2 occurred, so that low
temperatures effected the system when it was doped with the mix of pharmaceutical compounds.
In summary, the incorporation of the pharmaceuticals produced a shock in the microorganisms and
biomass decreased. In general terms, the reduction of biomass is more significant when the temperature
is lower and the reduction of biomass decreases at temperatures between 21–28 ◦C.
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The organic matter removal by the systems is shown in Table 4 for each condition tested.
Table 4. Organic matter removal efficiency of the process measured as BOD5, COD, and TOC during the experiments.
Cycle
BOD5 COD TOC
Steady State Doping 1 Doping 2 Doping 3 Steady State Doping 1 Doping 2 Doping 3 Steady State Doping 1 Doping 2 Doping 3
1 92.07 ± 7.17 97.87 ± 0.89 95.83 ± 2.77 94.46 ± 6.05 87.63 ± 3.87 86.72 ± 2.56 85.87 ± 3.88 83.95 ± 0.58 87.81 ± 1.40 87.54 ± 1.22 86.44 ± 1.86 85.31 ± 2.32
2 94.46 ± 6.34 98.16 ± 0.89 90.98 ± 10.82 - 86.87 ± 2.17 79.62 ± 14.69 87.89 ± 5.40 - 88.64 ± 1.04 86.56 ± 8.33 88.17 ± 4.69 -
3 97.48 ± 2.78 98.81 ± 0.71 99.34 ± 0.50 99.27 ± 0.46 89.86 ± 4.58 90.53 ± 4.63 90.89 ± 4.44 87.30 ± 2.15 87.98 ± 1.80 90.42 ± 1.34 90.61 ± 0.69 90.41 ± 0.32
4 97.90 ± 1.17 98.42 ± 0.21 97.87 ± 1.54 96.04 ± 1.48 91.19 ± 1.09 93.60 ± 3.07 92.07 ± 4.4 88.55 ± 6.36 86.98 ± 1.46 90.43 ± 0.95 85.03 ± 2.15 86.39 ± 3.48
Water 2019, 11, 1785 8 of 14
In general, the values of BOD5 in the four cycles were above 92% in the steady state and above
90% in the dopings. In cycle 3, with an HRT of 6 h and a temperature of 28 ◦C, the removal of BOD5
was higher than in other cycles, with values of about 98% in the steady state to about 99% in doping
2. The COD had a removal performance somewhat lower than BOD5. The values in the steady state
varied from about 87% in cycle 2 to about 91% in cycle 4. The values in the different dopings ranged
from about 80% in cycle 2 to about 94% in cycle 4. Cycles 3 and 4 with 6 and 10 h of HRT, respectively,
and temperatures of 28 ◦C and 17 ◦C, respectively, had very close values of COD removal. Organic
matter was also measured with the TOC, which is intimately related to the COD, so the values are very
similar. The highest performances were in cycles 3 and 4, ranging from about 85% in doping 3 of cycle
1 to about 91% in doping 2 of cycle 3.
The ANOVA test did not show statistically significant differences between the steady state and
the dopings in the different cycles. The organic matter consumption, independently of the decrease of
MLSS in the bioreactor, remained constant. Shariati et al. [25] used an MBR system for the removal of
pharmaceutical compounds from wastewater and demonstrated that the most important parameters
for the removal of these compounds are COD and MLSS; increasing the COD in the medium decreased
the pharmaceutical compound removal, while increasing the MLSS favored it.
On the one hand, in Table 4, it can be seen that the removal of BOD5 in the three dopings in
cycle 1 was slightly higher than in the steady state. The same occurs with cycle 2. Cycles 3 and 4
with the MBBR-MBR system removed practically the same amount during the three dopings as in the
stationary state. The BOD5 performances were high in the four cycles, with values above 92% and up
to about 99%. Leyva–Díaz et al. [14] achieved a removal of about 98.9% with an MBBR-MBR system
working for 26 h of HRT and at 99.1% with an MBR system, although the biomass was lower in the
system. Furthermore, 91% and 92% of COD were removed with the MBBR-MBR and MBR systems,
respectively. Therefore, in both systems, high percentages were achieved in the removal of organic
matter, but both had lower HRTs. Cycles with biofilm removed slightly more BOD5 than cycles with
only suspended biomass, which could be due to a higher biomass concentration as a consequence of
its growth as biofilm onto the carriers.
On the other hand, COD removal is also shown in Table 4. With the MBBR-MBR system, slightly
more organic matter is removed during the different dopings than with the MBR system. Furthermore,
either less COD is removed by adding the different concentrations of pharmaceutical mix or the
removal in the different dopings is kept constant with respect to the steady state. In cycle 1 with the
MBR system, the removal is lower in the three dopings than in the steady state; it decreased with an
increased concentration of the pharmaceutical mix. Cycle 2 started removing less (about 80%), and in
doping 2, it removed the same as in the stationary state (about 88%). In cycles 3 and 4, the removal
remained practically constant even when the pharmaceutical mix was introduced, which means that the
COD removal in the hybrid MBBR-MBR system was less affected by inhibitory substances. This could
be due to the presence of attached biomass as biofilm, which entails a protected form of growth.
No relevant differences were observed in relation to the TOC. With the MBR system (cycles 1
and 2), regardless of temperature and HRT, TOC removal was slightly lower than in the steady state.
However, for cycle 3 (MBBR-MBR system), removal was slightly higher than in the steady state, and for
cycle 4 (MBBR-MBR system), the observed removal is comparable to that of the steady state, as is the
case in dopings 2 and 3 in cycle 4, corresponding to the lowest value of temperature for this system.
In general, the removal of COD and TOC in the system is not as high as BOD5, ranging from about 80%
to about 94% in COD removal and from about 85% to about 91% in TOC removal.
3.3. Kinetic Modeling
Table 5 shows the kinetic parameters for heterotrophic bacteria, as well as values of rsu,H for cycles
1, 2, 3, and 4 for MBR and MBBR-MBR.
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Table 5. Kinetic parameters for heterotrophic biomass in the absence (control) and presence (doping)
of carbamazepine, ciprofloxacin, and ibuprofen for the four operation cycles of membrane bioreactor
(MBR) and bed biofilm reactors–membrane bioreactor (MBBR-MBR).
Parameter
Operation Phase
Control Doping 1 Doping 2 Doping 3
MBR
Cycle 1
YH (mgVSS mgCOD−1) 0.6344 0.6156 0.6231 0.6205
µm,H (h−1) 0.0170 0.0054 0.0158 0.0358
KM (mgO2 L−1) 8.0550 1.6285 9.2261 14.9804
bH (day−1) 0.0557 0.0606 0.0564 0.0728
rsu,H (mgO2 L−1 h−1) 107.84 38.98 91.56 125.05
Cycle 2
YH (mgVSS mgCOD−1) 0.6090 0.6232 0.6290 -
µm,H (h−1) 0.0239 0.1835 0.2259 -
KM (mgO2 L−1) 19.8920 129.6460 173.0295 -
bH (day−1) 0.0540 0.0426 0.0529 -
rsu,H (mgO2 L−1 h−1) 150.86 699.94 1024.48 -
MBBR-MBR
Cycle 3
YH (mgVSS mgCOD−1) 0.6462 0.6007 0.6446 0.6093
µm,H (h−1) 0.0200 0.0152 0.0199 0.0141
KM (mgO2 L−1) 17.4453 17.9443 17.5387 13.0614
bH (day−1) 0.0726 0.0435 0.0962 0.0760
rsu,H (mgO2 L−1 h−1) 72.37 106.48 116.34 76.12
Cycle 4
YH (mgVSS mgCOD−1) 0.6058 0.5824 0.5845 0.5975
µm,H (h−1) 0.0252 0.1025 0.1079 0.0175
KM (mgO2 L−1) 13.2984 78.5140 81.3655 4.9995
bH (day−1) 0.0769 0.0654 0.0702 0.1427
rsu,H (mgO2 L−1 h−1) 146.14 206.04 222.92 69.35
The yield coefficient for heterotrophic biomass (YH) was slightly lower in the presence of
pharmaceuticals, with the exception of cycle 2, which corresponded to the MBR working for 10 h of
HRT. In general, µm,H and KM increased with the progressive dopings, with the exception of cycle 3,
which corresponded to the MBBR-MBR working for 6 h of HRT. The influence of these variations
on kinetic parameters of heterotrophic biomass is included in the values of rsu,H for the different
cycles analyzed.
Regarding the effect of the mix of carbamazepine, ciprofloxacin, and ibuprofen in increasing
concentrations on the heterotrophic biomass within the MBR system, it must be highlighted that the
rsu,H decreased in the presence of the pharmaceuticals for doping 1 and doping 2 (about 64% and
15%, respectively) and increased for doping 3 (about 16%) in cycle 1. These results could indicate the
existence of an adaptation period for heterotrophic biomass. However, rsu,H significantly increased for
dopings 1 and 2 (about 364% and 579%, respectively) in cycle 2. This difference in behavior between
Water 2019, 11, 1785 10 of 14
the two cycles could be due to the most favorable operation conditions for cycle 2, as the MBR worked
for 10 h of HRT and 21.7 days of SRT, compared with the MBR from cycle 1 (HRT = 6 h, SRT = 11.2 day).
In relation to the influence of the mix of pharmaceuticals on the heterotrophic biomass within the
MBBR-MBR, it must be pointed out that the rsu,H showed a higher increase for doping 1 and doping 2
(about 47% and 61%, respectively) than for doping 3 (about 5%) in cycle 3. This could indicate that the
adaptation response of the heterotrophic biomass of MBBR-MBR was better than that corresponding to
an MBR under the same HRT (cycle 1). This could be due to the higher temperature for the MBBR-MBR
(28.1 ºC) than that obtained for the MBR (21.5 ºC). Moreover, the attached biomass from the MBBR-MBR
constitutes a protected form of growth, which is generally considered less sensitive to toxic influents
and hostile environments [26]. In light of this, the behavior of the MBBR-MBR was similar in cycle 4,
with the exception of doping 3. The rsu,H increased for doping 1 and doping 2 (about 41% and 53%,
respectively), although rsu,H lessened for doping 3 (about 53%). While rsu,H decreased for doping 3
in relation to doping 1 and doping 2 in cycles 3 and 4, the reduction was more significant in cycle 4.
This could be due to the lower temperature (17.6 ◦C) compared to the temperature of cycle 3 (28.1 ◦C),
though working at higher values of HRT and SRT (Table 1). The comparison between cycles 2 and 4
shows that the MBR system had more favorable substrate degradation rates than those observed for
the MBBR-MBR at similar operation conditions.
In general, the decay coefficient increased under the different dopings in relation to the control
phase with the exception of cycle 2, which corresponded to the MBR working for 10 h of HRT, 21.7 days
of SRT, and 12.6 ◦C. This suggests that the cell decay rate also increased in the presence of these
chemicals, which could explain the reduction of MLSS, as indicated in Table 3.
The combined effect of bH and rsu,H made similar removal efficiencies of organic matter in both the
control and doping phases possible (Table 4). Aubenneau et al. [27] analyzed the effect of carbamazepine
on an MBR system and did not observe any variation of organic matter removal under exogenous
respiration; this explained the increase of bH as a consequence of higher maintenance requirements.
Kraigher et al. [28] explained this by the presence of a different bacterial community, whereas
Wang et al. [29] indicated a change in the metabolic pathways of the substrate. Vasiliadou et al. [30]
analyzed the influence of pharmaceuticals on an AS system and also indicated modifications of
the microbial community as the reason for the adaptation of microorganisms in the presence of
these chemicals.
Calero–Díaz et al. [12] investigated an identical mix of pharmaceuticals and obtained similar
results for an MBR working at HRT for 6 h, SRT for 7.5 days, and average value for MLSS of 4551 mg L−1.
These authors determined the increases in the values of rsu,H and bH in relation to the control phase,
proposing that these results were caused by chemical stress once the pharmaceuticals were introduced.
Leyva–Díaz et al. [31] analyzed the effect of nalidixic acid (antibiotic) on a NIPHO activated sludge
reactor working at HRT values of 2.8–3.8 h, temperatures of 12.6–14.8 ◦C, SRT values of 11.0–12.6 days,
and biomass concentrations of 1400–1700 mgVSS L−1. These authors also found an increase in the
values of rsu,H and argued that the heterotrophic biomass counteracted a possible physiological
stress by increasing the rsu,H to favor its acclimatization. In light of this, Bouki et al. [32] stated that
the environmental conditions in wastewater treatment plants are suitable for the acquisition and
proliferation of antibiotic-resistant bacteria, which may transfer resistant genes to resident bacteria.
3.4. Nitrogen Removal
The extent of the removal of nitrogen in the form of ammonium (N-NH4+) in both the MBR and
the hybrid MBBR-MBR system is shown in Table 6.
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Table 6. N-NH4+ removal rate (%).
Cycle Steady State Doping 1 Doping 2 Doping 3
1 9.00 ± 2.08 - - -
2 6.36 ± 1.81 3.48 ± 0.62 0.15 ± 0.21 -
3 22.61 ± 5.07 9.84 ± 6.02 6.00 ± 1.02 1.06 ± 1.84
4 6.24 ± 3.32 0.66 ± 0.28 0.04 ± 0.02 1.42 ± 1.03
Unlike the organic matter, the introduction of the pharmaceutical compounds mix in the system
affects the removal of N-NH4+ considerably.
A statistical study on the removal of N-NH4+ was carried out with the ANOVA test. In this case,
the nitrogen removal was compared between the steady state and each doping concentration for each
of the cycles. The MBBR-MBR system did not show statistically significant differences, while the MBR
system did. This is because the biofilm systems are more stable and soften the shocks suffered by the
system when the pharmaceutical compound mix is introduced [33].
With warmer temperatures in the steady state, as in cycles 1 and 3, the removal of N-NH4+ is
higher than when the temperature is colder (around 6% for cycles 2 and 4), and especially in cycle 3,
this removal is above 22% with a temperature of 28 ◦C. Regardless of the system used, the temperature
is the operational variable that most affects the behavior of the reactor, and in the steady state, more
N-NH4+ is removed. However, when the pharmaceutical compound mix is introduced into the system,
the removal decreases considerably until no more removal was detected in cycle 1.
The hybrid MBBR-MBR system had a better behavior in the removal of N-NH4+, although with
very low removal values, especially in cycle 4. The removal decreased in the three dopings with
respect to the stationary state, by about 13%, 17%, and 22%, respectively, in cycle 3, and for cycle 4,
the difference was about 6%, 6%, and 5% less, respectively.
The N-NH4+ removal in the MBR system was greatly affected by doping. In cycle 2 with 10 h
of HRT and about 13 ◦C, N-NH4+ removal was detected, but with a very low performance. These
removal performances differed with respect to the steady state by about 3% and 6% for dopings 1 and 2,
respectively. In doping 3 of cycle 2, there is no N-NH4+ data because the system suffered a shock when
introducing the pharmaceuticals compound, proliferating filamentous bacteria that caused sludge
bulking of the system, resulting in the total loss of the biomass.
The COD and nitrogen removal goes in parallel with the removal of pharmaceutical compounds,
especially in biofilm systems in which it is involved in co-metabolic activities [34].
4. Conclusions
Given the results obtained in a membrane bioreactor pilot plant operating at similar MLSS
concentration (about 5.5 g/L) considered whether or not, with a moving bed biofilm reactor for
treating real urban wastewater for 6 and 10 h of HRT under three different shocks of pharmaceuticals
(carbamazepine, ciprofloxacin, and ibuprofen) with increasing concentrations, the following conclusions
were drawn:
• Organic matter removal was higher in the MBBR-MBR technology for the same HRT and
similar MLSS.
• From a kinetic perspective, MBBR-MBR is more suitable for low HRT (6 h) and MBR is more
effective for high HRT (10 h). This might be due to the fact that biofilm systems are less sensitive
to more unfavorable operating conditions than the MBR systems.
• The removal of N-NH4+ considerably decreased in both MBR and MBBR-MBR when the
pharmaceutical compounds mix was introduced into the system, until no removal was detected
in cycle 1.
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Considering the above, MBR and MBBR-MBR are adequate technologies to treat real urban
wastewater exposed to the impact of pharmaceutical compounds; however, the MBBR-MBR technology
reduces the negative effect of a pharmaceutical shock in the organic matter removal and in the
heterotrophic biomass behavior.
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